Nanobiologics is a breakthrough in the field of science and defines a novel technology for developing immunisations based on nanoparticles, water coherent domains and ultra dilutions that allows for the preparation of potentially safe and readily scalable formulations by a patent pending process. Nanobiologics integrates scientific knowledge from different fields of science into a multidisciplinary approach to effectively trigger relevant homeostatic mechanisms leading to beneficial physiological outcomes against targeted diseases. Nanobiologics products are designed for oral delivery and will stay stable and safe when stored, distributed and administered at room temperate therefore not requiring any cold chain storage which addresses significant challenges faced currently with developed immunisations. The development of products using Nanobiologics is dependent on Moleculebase and Nantigen for the selection of appropriate raw materials in the preparation of ultra diluted prophylactic formulations to target specific diseases.

Based on the proposed interaction of ultra-diluted substances with the immune system, biological material derived from the infectious pathogens related to the targeted disease have been identified for the preparation of disease specific ultra dilutions. These particular formulations defined as Nantigen are designed to activate the immune system and induce a beneficial response by delivering relevant signals and ultra-low doses of antigens. Our patent pending process for preparing these Nantigens are particular to the nature of the causative pathogen.

Moleculebase is a platform for identification of homeostatic mechanisms and physiological pathways underlying the natural and beneficial response to diseases, and also the molecules that are known to activate such pathways. Under this concept and by a rational and comprehensive analysis of available scientific data a combination of  molecules able to simulate the homeostatic mechanisms that lead to beneficial physiological outcomes can be devised.